Page results
-
Breathlessness (dyspnoea) is an unpleasant sensation of uncomfortable, rapid or difficult breathing.
-
Meet Mohammod, a booking coordinator in our Proton Beam Therapy unit, who supports patients and their families throughout their treatment.
-
We are expanding the type of results that will be shared with patients through our patient portal MyCare UCLH.
-
BBC News at the NHNN
-
Information about activating your MyCare UCLH app.
-
The sleep service at UCH is run within the department of Thoracic Medicine. We have particular expertise in the diagnosis and management of ventilatory disorders during sleep, including obstructive sleep apnoea syndrome, sleep disordered breathing and assessment of respiratory failure.
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
File results
-
FOI/2022/0530 - Neonatal sepsis guidance
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology